Volume 64, Issue 8 , Pages 1214-1220, August 2006
Effect of Interferon-Alpha-2b on Porcine Mesenchymal Stem Cells
Purpose
Patients undergoing enucleation and adjuvant interferon therapy for giant cell jaw tumors have been observed to exhibit exuberant bone formation in the resultant defects. We hypothesize that interferon promotes bone formation by enhancing mesenchymal stem cell (MSC) differentiation and by stimulating osteoblasts. This is a preliminary study to determine the effects of interferon on porcine mesenchymal stem cells (pMSCs) in culture.
Materials and Methods
Isolated pMSCs were grown under the following conditions: 1) MSCs alone (negative control); 2) MSCs + osteogenic supplements (positive control); and 3) MSCs + interferon (experimental). Cell cultures were evaluated morphologically, by quantitative DNA analysis, and quantitative and qualitative alkaline phosphatase analysis.
Results
Cells treated with interferon exhibited a slower but constant proliferation rate, did not clump, and produced more alkaline phosphatase as compared with the negative control.
Conclusion
The data indicate that interferon may act to differentiate MSCs into osteoblasts and to stimulate metabolic activity while not increasing the proliferation rate.
To access this article, please choose from the options below
This study was supported in part by a grant from the Hanson Foundation, Boston, MA (MJT, PI); NIH (K23-DE. 14070-01, MJT, PI); by the Department of Oral and Maxillofacial Surgery Research Fund and the Laboratory for Tissue Engineering and Organ Fabrication; and by a grant from Therics, Inc (Princeton, NJ).
PII: S0278-2391(06)00522-2
doi:10.1016/j.joms.2006.04.006
© 2006 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
Volume 64, Issue 8 , Pages 1214-1220, August 2006
